Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease)

Minerva Cardioangiologica

Volumn 50, Issue 3, 2002, Pages 221-232

  Sabba C ^a   Pasculli, G ^a   Cirulli, A ^a   Gallitelli, M ^a   Virgilio, G ^a   Resta, F ^a   Guatamacchia, E ^a   Palasciano, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ARTERIOVENOUS MALFORMATION; ARTIFICIAL EMBOLISM; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE STUDY; CONGENITAL MALFORMATION; ECHOGRAPHY; EPISTAXIS; FEMALE; GENETICS; HEPATIC ARTERY; HUMAN; LIVER VEIN; MALE; MIDDLE AGED; PULMONARY ARTERY; PULMONARY VEIN; RADIOGRAPHY; RENDU OSLER WEBER DISEASE; REVIEW;

ANGIOGRAPHY; ARTERIOVENOUS MALFORMATIONS; EMBOLIZATION, THERAPEUTIC; EPISTAXIS; FEMALE; HEPATIC ARTERY; HEPATIC VEINS; HUMANS; MALE; MIDDLE AGED; PULMONARY ARTERY; PULMONARY VEINS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0036617490     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (96)

1. Shovlin CL, Hughes JMB, Tuddenham EGD, Tempuley I, Perembelon YF, Scott J et al. A gene for hereditary hemorrliagic telangiectasia maps to chromosome 9q3. Nat Genet 1994;6:205-9.
2. Vincent P, Plauchu H, Hazan J, Faure S, Weissenbach Y, Godet J. A third locus for hereditary hemorrhagic telangiectasia nups to chromosome 12q. Hum Mod Genet 1995;4:945-50.
3. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918-24.
4. King CR, Lonrein EW, Reiss J. Central nervous system arteriovenous malformations in multiple generations of a family with hereditary hemorrhagic telangiectasia. Clin Genet 1977;12:372-81.
5. Sutton HG. Epistaxis as an indication of impaired nutrition and of degeneration of the vascular system. Med Mirror 1864;1:769-81.
6. Babington B. Hereditary epistaxis. Lancet 1865;2:362.
7. Rendu M. Epistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Gaz Hop 1896;68:1322-3.
8. Osler W. On a family form of recurring epistaxis with multiple teleangiectases of the skin and mucous membranes. Bull Johns Opkins Hosp 1901;12:333-7.
9. Osler W. On a multiple teleangiectases of the skin with recurring haemorrhages. Q J Med 1907;1:53-8.
10. Weber FP. Multiple hereditary developmental angiomate of the skin and mucous membranes associated with recurring haemorrages. Lancet 1907;2:160-2.
11. Hanes FM. Multiple hereditary telangiectases causing hemorrhage (hereditary hemorrhagic telangiectasia). Bull Johns Hopkins Hosp 1909;20:63-73.
12. Plauchu H, Bideau A. Epidémiologie et constitution d'un registre de population à propos d'une concentration géographique d'une maladie héréditaire rare. Population 1984;4-5:765-86.
13. Guttmacher AE, Upton MD. Hereditary haemorrhagic teleangiectasia: a disorder in search of the genetics community. Am J Med Genet 1994;52:252-3.
14. Johnson DW, Berg JN, Gallione CJ, Morondel I, Yoon SJ, Stenzel TT et al Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-95.
15. Fernandez-Ruiz E, St-Jacques S, Bellon T, Letarte M, Bernabeu C. Assignment of the human endoglin gene (END) to 9q34qter. Cytogenet Cell Genet 1993;64:204-7.
16. Mc Donald MT, Papenberg KA, Gosh S, Glatfelter A, Biesecker B, Hembold E et al. A disease locus for hereditary hemorragic telangiectasia maps to chromosome 9q33-34. Nat Genet 1994;6:197-204.
17. Heutink P, Haitjema T, Breedveld GJ, Janssen B, Sandkuijl L, Bontekoe CJM et al. Linkage of hereditary hemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity. J Med Genet 1994;391:933-6.
18. Mc Allister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson C et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-51.
19. Berg JN, Gallione CJ, Stenzel TT, Johnson DW, Allen WP, Schwartz CE et al. The activin receptor like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 1997;61:60-7.
20. Johnson DW, Berg JN, Gallione CJ, Mc Allister KA, Warner JP, Hembold EA. A second locus for hereditary hemorrhagic telangiectasia mapped to choromosome 12. Genome Res 1995;5:21-8.
21. Kjeldsen AD, Brusgaard K, Poulsen L, Kruse T, Rasmussen K, Green A et al. Mutations in the ALK-1 gene and the phenotype of hereditary hemorrhagic telangiectasia in two large Danish families. Am J Med Genet 2001;98:298-302.
22. Porteous MEM, Curtis A, Williams O, March UD, Bhattachara SS, Burn J et al. Genetic heterogeneity in hereditary hemorrhagic telangiectasia. J Med Gen 1994;31:925-6.
23. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J et al. Endoglin is a component of the trasforming growth factor-β receptor system in human endothelial cells. J Biol Chem 1992;267:9027-30.
24. Yamashita H, Ichijo H, Grimsby S, More A, Miyasono K. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β. J Biol Chem 1994;269:1995-2001.
25. Cymerman U, Vera S, Pece-Barbara N, Bourdeau A, White RI Jr, Dunn J et al. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr Res 2000;47:24-35.
26. Berg JN, Guttmacher AE, Marchuk DA, Porteous MEM. Clinical heterogeneity in hereditary hemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 1996;33:256-7.
27. Mc Allister KA, Lennon F, Bowles-Bieseker B. Genetic heterogeneity in hereditary hemorrhagic telangiectasia: possible correlation with clinical phenotype. J Med Genet 1994;31:927-31.
28. Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW. Screening of family members of patients with HHT. Am J Med 1995;99:519-24.
29. Aassar OS, Friedman CM, White RI Jr. The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 1991;101:977-80.
30. Harrison DFN. Use of estrogen in treatment of familial hemorrhagic teleangiectasia. Laryngoscope 1982;92:314-20.
31. Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia: a double-blind controlled clinical trial. Acta Med Scand 1981;209:393-6.
32. Plauchu H, De Chadarevian JP, Bideau A, Robert J. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989;32:291-7.
33. Bravemann IM, Keh A, Jacobson BS. Ultrastructure and three-dimensional organization of the teleangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 1990;95:422-7.
34. Kjeldsen AD. Epidemiological and clinical aspects of hereditary hemorrhagic telangiectasia. Mb [thesis]. Osler. Odense, Denmark: Odense University, 1998.
35. White RI Jr, Linch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988;169:663-9.
36. Adams HP Jr, Subbiah B, Bosch EP. Neurologic aspects of hereditary hemorrhagic telangiectasia: report of 2 cases. Arch Neurol 1977;34:101-4.
37. Hewes RC, Auster M, White RI Jr. Celebral embolism-first manifestation of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 1985;8: 151-5.
38. Swanson DL, Dahl MV. Antibiotic prophylaxis for patients with hereditary hemorrhagic telangiectasia. J Am Acad Dermatol 1992;26:282-3.
39. Gelfand MS, Stephens DS, Howell EI, Alford RH, Kaiser AB. Brain abscess: association with pulmonary arteriovenous fistula and HHT. Report 3 case. Am J Med 1988;85:718-20.
40. Odgson CH, Burcell HB, Good CA, Clagett OT. Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous fistula: survey of a large family. N Engl J Med 1959;261:625-36.
41. Laroche CM, Wells F, Sheerson J. Massive hemotorax due to enlarging arteriovenous fistula in pregnancy. Chest 1992;101:1452-4.
42. Dines DE, Seward JB, Bernatz PE. Pulmonary arteriovenous fistula. Mayo Clinic Proc 1993;58:176-81.
43. Shovlin CL, Winstok AR, Peters AM, Jackson JE, Hughes JM B. Medical complications of pregnancy in hereditary hemorrhagic telangiectasia. Q J Med 1995;88:879-87.
44. Dines DE, Arms RA, Gmes MR. Pulmonary arteriovenous fistulas. Mayo Clinic Proc 1974;49:460-5.
45. Thompson RD, Jackson J, Peters AM, Dore CJ, Hughes JMB. Sensitivity and specificity of radioisotope right-left shunt measurements and pulse oximetry for the early detection of pulmonary arteriovenous malformations. Chest 1999;115:109-13.
46. Nauthakumar K, Graham AT, Robinson TI, Grande P, Pugash RA, Clarke JA et al. Contrast echocardiography for detection of pulmonary arteriovenous malformations. Am Heart J 2001;141(2):243-6.
47. Remy J. Remy-Jardin M, Wattinne L. Pulmonary arteriovenous malformations: therapeutic options. Ann Thorac Surg 1993;56:253-8.
48. Remy J, Remy-Jardin M, Giraud F, Wattinne L. Angioarchitecture of pulmonary arteriovenous malformations: clinical utility of three-dimensional helical CT. Radiology 1994;191:657-64.
49. Haitjema TJ, Overtoom THC, Westermann CJJ, Lemmers JW. Embolization of pulmonary arteriovenous malformations: results and follow-up in 32 patients. Thorax 1995;50:719-23.
50. Kjeldesen A, Oxhoj H, Andersen PE, Elle B, Jacobson JP, Vase P. Pulmonary arteriovenous malformations. Screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest 1999;116:432-9.
51. Whyte MKB, Peters AM, Hughes JMB, Henderson BL, Bellingan GJ, Jackson JE et al. Quantification of right to left shunt at rest and during exercise in patients with pulmonary arteriovenous malformations. Thorax 1992;47:790-6.
52. Wirth JA, Pollack JS, White RI. Pulmonary arteriovenous malformations. Curr Pulmonol Crit Care Med 1996;17:261-98.
53. Fulbright RK, Chaloupka JC, Putman CM, Sze GK, Merriam MM, Lee GK et al. MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. Am J Neuroradiol 1998;19:477-84.
54. Willinsky RA, Burrows B. Multiple cerebral arteriovenous malformations: review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology 1990;32:207-10.
55. Steele JS, Nath PU, Porteous MEM. An associaton between migrations aura and hereditary hemorrhagic telangiectasia. Headache 1993;33:145-8.
56. Roman G, Fisher M, Perl DP, Poser CM. Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and reviews of literature. Ann Neurol 1978;4:130-44.
57. Guttmacher A, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918-24.
58. Bernard G, Mion F, Henry L, Plauchu H, Paliard P. Hepatic involvement in hereditary hemorrhagic telangiectasia: clinical, radiological and hemodynamic studies of 11 cases. Gastroenterology 1993;105:482-7.
59. Martin GA, The liver in hereditary hemorrhagic telangiectasia. An inborn error of vascular structure with multiple manifestations: a reappraisal. Gut 1978;19:531-7.
60. Weik C, Greiner L. The liver in hereditary hemorrhagic telangiectasia (Weber-Rendu-Osler disease). Scand J Gastroenterol 1999;34:1241-6.
61. Lin JH, Yang PM, Tsang YM, Hsieh FJ. Sequential Doppler sonographic studies of embolization in a patients with hepatic involved in HHT. Correlation with angiographic findings. J Formos Med Assoc 1999;98:633-8.
62. Vase P, Grove O. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia: a clinical analysis. J Med Genet 1992;29:257-30.
63. Reilly PJ, Nostrant TT. Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 1984;79:363-7.
64. Halpern M, Turner AF, Citron BP. Hereditary hemorrhagic telangiectasia: an angiographic study of abdominal visceral angiodysplasias associated with gastrointestinal hemorrhage. Radiology 1968;90:1143-9.
65. Rutgeerts P, Van Gompel F, Geboes K, Vantrappen G, Broeckaert L, Coremas G. Long term result of treatment of vascular malformations of the gastrointestinal tract by neodymium Yag-laser photocoagulation. Gut 1985;26:586-93.
66. Gostout CJ, Bowyer BA, Ahlquist DA, Viggiano TR, Balm RK. Mucosal vascular malformations of the gastrointestinal trait: clinical observations and results of endoscopic neodymim-yttrium-aluminium-garnet laser theraphy. Mayo Clin Proc 1988;63:993-1003.
67. Cello IP, Grendell JH. Endoscopic laser treatment for gastrointestinal ectasias. Ann Intern Med 1986;104:352-4.
68. Van Cutsem F, Rutgeerts P, Vantrappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 1990;335:953-5.
69. Peery WH. Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Am J Med 1987;82:989-97.
70. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJJ et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Gen 2000;6:91(1):66-7.
71. Porteous MEM, Burn J, Proctor SJ. Hereditary hemorrhagic telangiectasia: clinical analysis. J Med Genet 1992;29:527-30.
72. Gallitelli M, Virgilio G, Papagni L, Palasciano G. Sabbà C. Efficacy of ur usually hight doses of tranexamic acid for the treatment of epistaxis in hereditary hemorragic telangiectasia. IVth HHT Scientific Conference, Tenerife, 2001.
73. Pau H, Carney AS, Walker R, Murky GE. Is oestrogen therapy justifiec in the treatment of hereditary hemorrhagic telangiectasia: a biochemical evaluation. Clin Otolaryngol 2000;25:547-50.
74. Lake CF. Management of epistaxis in HHT. Arch Otolaryngol 1987;103:627-30.
75. Haq AU, Glas, J. Netchvolodoff CV, Bower LM. Hereditary hemorrhagic telangiectasia and danazol. Ann Intern Med 1988;109:171.
76. Parkin JL, Dixon JA. Laser photocoagulation in hereditary hemorrhage telangiectasia. Otolaryngol Head neckSurg 1981 89:204-8.
77. Rebiz EE, Parks S, Shapshay SM. Management of epistaxis in hereditaiy hemorrhagic telangiectasia with neodymium; yttrium-aluminium-garnet laser photocoagulation. Oper Tech Otolaryngol Hed Neck Surg 1991;2:177-82.
78. Sanders WH. Septal dermoplasty for hereditary hemorrhagic telangiectasia and other conditions. Otoryngol Clin North Am 1973;6:745-55.
79. Elden L, Montanera W, Terbrugge K, Willinsky R, Lasjinnias P, Charles D. Angiographic embolization for the treatment of epistaxis: a review of 108 cases. Otolaringol Hed Neck Surg 1994;111:44-50.
80. Morelli JG, Huff JC, Weston WL. Treatment of congenital telangiectatic vascular malformations with the pulsed dye-laser (585). Pediatrics 1993;92:603-7.
81. Hillert C, Broering DC, Gundlach M, Knoefel WT, Izbicki JR, Rogiers C. Hepatic involvement in hereditary hemorrhagic telangiectasia: unusual indication for liver transplatantion. Liver Transpl 2001;7:266-8.
82. Bourgeois N, Delcour C, Deviere J, Francois A, Lambert M, Cremer M et al. Osler-Weber-Rendu disease associated with hepatic involvement and high output heart failure. J Clin Gastroenterol 1990;12:236-8.
83. Whiting JH Jr, Korzenik JR, Miller FJ Jr, Pollak JS, White RI Jr. Fatal outcome after embolotherapy for hepatic arteriovenous malformations on the liver in 2 patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol 2000;11:855-8.
84. White R Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. JVIR 1996;7:787-804.
85. White RI, Pollack JS. Pulmonary arteriovenous malformations: option for management. Ann Thorac Surg 1994;57:517-24.
86. Hughers JMB, Allison DJ. Pulmonary arteriovenous malformations: the radiologist replaces the surgeon. Clin Radiol 1990;41:519-21.
87. Saluja S, Henderson KJ, White RI Jr. Embolotherapy in the bronchial and pulmonary circulation. Radiologic Clin North Am 2000;38:425-45.
88. Puskas JD, Allen MS, Moncure AC, Wain JC Jr, Hilgenberg AD, Wright C et al. Pulmonary arteriovenous malformations: therapeuthic options. Ann Thorac Surg 1993;56:253-8.
89. Andersen PE, Kjeldsen AD, Oxhoy H, Vase P, White RI Jr. Embolotherapy for pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. (Rendu-Osler-Weber). Acta Radiol 1998;39:723-6.
90. White RI, Pollak JS. Pulmonary arteriovenous malformations: diagnosis with three-dimensional helical CT. A break through without contrast media. Radiology 1994;191:613-4.
91. Robertson RJH, Robertson IR. Pulmonary arteriovenous malformations. Thorax 1995;50:707-8.
92. Hughes JMB. Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia. Sem Respir CLU Care Med 1998;19:79-89.
93. Dutton JAE, Jackson JE. Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients. AJR 1995;165:1119-25.
94. Remy-Jardin M, Wattinne L, Remy J. Transcatheter occlusion of pulmonary arterial circulation and collateral supply: failures, incidents and complications. Radiology 1991;180:699-705.
95. Coley SC, Jackson JE. Pulmonary arteriovenous malformations. Clin Radiol 1998;53:396-404.
96. Lee DW, White RI Jr, Egglin TK, Pollak JS, Fayad PB, Wirth JA et al. Embolotherapy of large pulmonary arteriovenous malformations: long-term result. Am Thorac Surg 1997;64:530-40.